Literature DB >> 21873312

C5a contributes to intraocular inflammation by affecting retinal pigment epithelial cells and immune cells.

Mengjun Hu1, Baoying Liu, Shayma Jawad, Diamond Ling, Megan Casady, Lai Wei, Robert B Nussenblatt.   

Abstract

BACKGROUND: The complement activation molecule C5a has been found in the eye and is implicated in the pathogenesis of ocular inflammatory diseases. In this study, the authors sought to investigate C5a's effects on human retinal pigment epithelial (RPE) cells and peripheral blood mononuclear cells (PBMCs), and on the interaction between RPE cells and PBMCs.
METHODS: Arising retinal pigment epithelia cell line-19 and PBMCs isolated from healthy donors were used in this study. Western blot, real-time PCR and cell surface receptor staining were used to detect C5a receptor expression. Real-time PCR was used to detect cytokine mRNA expression. A thiazolyl blue tetrazolium bromide assay was used to detect cell viability. Cells were stained with Annexin V and 7-aminoactinomycin D for an apoptosis assay. Cell proliferation was measured using a tritiated thymidine incorporation assay.
RESULTS: C5a receptors were present on RPE cells, and receptor expression was increased by pro-inflammatory cytokines. C5a suppressed RPE cells' production of transforming growth factor β2, an important immunosuppressive agent in the eye. In addition, the viability of RPE cells was decreased in the presence of C5a, and this effect was not due to apoptosis. C5a increased proliferation of PBMCs and upregulated their production of pro-inflammatory cytokines. Finally, C5a decreased RPE cells' ability to suppress immune cell proliferation.
CONCLUSION: The results provide a direct link between complement activation and intraocular inflammation. This line of information may help to understand the mechanism of the pathogenesis of intraocular inflammatory diseases. Moreover, the authors show that a close, reciprocal interaction between the innate immune system and the adaptive immune system may be involved in the development of such diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873312     DOI: 10.1136/bjophthalmol-2011-300235

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Inflammatory Mechanisms of Age-related Macular Degeneration.

Authors:  Jared E Knickelbein; Chi-Chao Chan; H Nida Sen; Frederick L Ferris; Robert B Nussenblatt
Journal:  Int Ophthalmol Clin       Date:  2015

2.  FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration.

Authors:  Nadine Reichhart; Gerhild Wildner; Olaf Strauß; Ahmad Samir Alfaar; Lucas Stürzbecher; Maria Diedrichs-Möhring; Marion Lam; Christophe Roubeix; Julia Ritter; Kathrin Schumann; Balasubramaniam Annamalai; Inga-Marie Pompös; Bärbel Rohrer; Florian Sennlaub
Journal:  J Neuroinflammation       Date:  2022-10-22       Impact factor: 9.587

3.  CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulation.

Authors:  Sijia Cao; Jay Ching Chieh Wang; Jiangyuan Gao; Matthew Wong; Elliott To; Valerie A White; Jing Z Cui; Joanne A Matsubara
Journal:  Br J Ophthalmol       Date:  2016-01-08       Impact factor: 4.638

4.  Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage.

Authors:  Carolina Brandstetter; Frank G Holz; Tim U Krohne
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

Review 5.  Aging is not a disease: distinguishing age-related macular degeneration from aging.

Authors:  Daniel Ardeljan; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2013-08-09       Impact factor: 21.198

6.  C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells.

Authors:  Yi Zhu; Bingling Dai; Yongguo Li; Hui Peng
Journal:  Mol Vis       Date:  2015-09-29       Impact factor: 2.367

7.  Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Wonjun Yang; Hyori Kim; Shinjae Chang; Dongjo Kim; Minseok Chang; Kihwang Lee; Junho Chung; Jeong Hun Kim
Journal:  Oncotarget       Date:  2017-07-11

8.  Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium.

Authors:  Catharina Busch; Balasubramaniam Annamalai; Khava Abdusalamova; Nadine Reichhart; Christian Huber; Yuchen Lin; Emeraldo A H Jo; Peter F Zipfel; Christine Skerka; Gerhild Wildner; Maria Diedrichs-Möhring; Bärbel Rohrer; Olaf Strauß
Journal:  Front Immunol       Date:  2017-06-15       Impact factor: 7.561

9.  Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.

Authors:  Beth Coughlin; Gloriane Schnabolk; Kusumam Joseph; Himanshu Raikwar; Kannan Kunchithapautham; Krista Johnson; Kristi Moore; Yi Wang; Bärbel Rohrer
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.